Cargando…
Can an effective SARS-CoV-2 vaccine be developed for the older population?
The emergence of SARS-CoV-2 and its inordinately rapid spread is posing severe challenges to the wellbeing of millions of people worldwide, health care systems and the global economy. While many younger people experience no or mild symptoms on infection, older adults are highly susceptible to life-t...
Autores principales: | Pawelec, Graham, Weng, Nan-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148425/ https://www.ncbi.nlm.nih.gov/pubmed/32300370 http://dx.doi.org/10.1186/s12979-020-00180-2 |
Ejemplares similares
-
Validation of the effectiveness of SARS-CoV-2 vaccines in older adults in “real-world” settings
por: Weng, Nan-ping, et al.
Publicado: (2021) -
Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
por: Pawelec, Graham, et al.
Publicado: (2021) -
Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants
por: Pawelec, Graham, et al.
Publicado: (2021) -
SARS-CoV-2 Vaccination: What Can We Expect Now?
por: Meurens, François, et al.
Publicado: (2022) -
HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)